EXCLUSIVE: Nanoantibodies offer new sea-lice hope
Hamburg-based biotechnology company AquaNab is developing a feed-based nanoantibody technology aimed at tackling sea lice, one of the aquaculture industry’s most persistent and expensive challenges.